Celgene nails down $7.2B takeover of Receptos

Eric Palmer

Thursday reported that it had completed its $ 7.2 billion buyout of . Celgene agreed to pay $ 232 per share for the San Diego-headquartered company, a nearly 18% premium.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS